Karl and Spencer discuss a tweet from Steve Crowder
This ensures they get the treatment they need
doi: 10.3390/jcm12010145 Retrieved from Hanssen, N
Most eligible patients still aren't receiving GLP-1 medications Even as GLP-1 trends climb, most people diagnosed with overweight or obesity are not receiving prescriptions
changes from baseline in fasting plasma glucose, blood pressure, fasting lipid profile and renal outcome (measured by change in eGFR), and adverse events relevant to the GLP-1 drug class were given specific attention
If its covered, you may have to pay a copay or deductible, but if its not covered, youll need to pay the full price, which is over $1,000 per month